population pharmacokinetics

https://www.mathworks.com/help/simbio/ug/modeling-the-population-pharmacokinetics-of-phenobarbital-in-neonates.html Model the Population Pharmacokinetics of Phenobarbital in Neonates - MATLAB & Simulink Example Perform nonlinear mixed-effects modeling using clinical pharmacokinetic data. the population matlab simulink model pharmacokinetics https://www.longdom.org/open-access/population-pharmacokinetics-and-optimization-of-the-dosing-regimen-ofdigoxin-in-adult-patients-2376-0419-1000147.pdf Population Pharmacokinetics and Optimization of the Dosing Regimen of Digoxin in Adult Patients population pharmacokinetics of the https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1130287/full Frontiers | Population pharmacokinetics of nalbuphine in patients undergoing general anesthesia... Purpose: The aim of this study was to build a population pharmacokinetics (PopPK) model of nalbuphine and to estimate the suitability of bodyweight or fixed ... population pharmacokinetics frontiers nalbuphine patients general https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2023.1093171/full Frontiers | Population pharmacokinetics of vancomycin in very low birth weight neonates Vancomycin dosing in very low birth weight (VLBW) neonates is challenging. Compared with the general neonatal population, VLBW neonates are less likely to ac... very low birth weight population pharmacokinetics frontiers vancomycin https://www.gov.uk/research-for-development-outputs/safety-efficacy-and-population-pharmacokinetics-of-fixed-dose-combination-of-artesunate-mefloquine-in-the-treatment-of-acute-uncomplicated-plasmodium-falciparum-malaria-in-india Safety, efficacy and population pharmacokinetics of fixed-dose combination of artesunate-mefloquine... In the treatment of acute uncomplicated Plasmodium falciparum malaria in India fixed dose combination population pharmacokinetics safety efficacy https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1083464/full Frontiers | Population pharmacokinetics of tigecycline in critically ill patients Objective: In critically ill patients, the change of pathophysiological status may affect the pharmacokinetic (PK) process of drugs. The purpose of this stud... population pharmacokinetics critically ill frontiers tigecycline patients https://pmc.ncbi.nlm.nih.gov/articles/PMC8636140/ Population Pharmacokinetics of Intravenous Amoxicillin Combined With Clavulanic Acid in Healthy and... Background: Data regarding antimicrobial pharmacokinetics (PK) in critically ill dogs are lacking and likely differ from those of healthy dogs. The aim of this... population pharmacokinetics https://pmc.ncbi.nlm.nih.gov/articles/PMC2764228/ Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and... Oritavancin is a novel glycopeptide antimicrobial agent with potent in vitro activity against a wide variety of gram-positive bacteria, including... population pharmacokinetics oritavancin healthy https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.873439/full Frontiers | Population Pharmacokinetics of Vancomycin in Pregnant Women Objective: Vancomycin is a glycopeptide antibacterial indicated for serious gram-positive infections. Pharmacokinetics (PK) of vancomycin have not been descr... population pharmacokinetics frontiers vancomycin pregnant women https://www.fda.gov/regulatory-information/search-fda-guidance-documents/population-pharmacokinetics Population Pharmacokinetics | FDA Clinical Pharmacology population pharmacokinetics fda

Robuta